Host-specificity of myxoma virus: Pathogenesis of South American and North American strains of myxoma virus in two North American lagomorph species
-
Add time:08/25/2019 Source:sciencedirect.com
The pathogenesis of South American and North American myxoma viruses was examined in two species of North American lagomorphs, Sylvilagus nuttallii (mountain cottontail) and Sylvilagus audubonii (desert cottontail) both of which have been shown to have the potential to transmit the South American type of myxoma virus. Following infection with the South American strain (Lausanne, Lu), S. nuttallii developed both a local lesion and secondary lesions on the skin. They did not develop the classical myxomatosis seen in European rabbits (Oryctolagus cuniculus). The infection at the inoculation site did not resolve during the 20-day time course of the trial and contained transmissible virus titres at all times. In contrast, S. audubonii infected with Lu had very few signs of disseminated infection and partially controlled virus replication at the inoculation site. The prototype Californian strain of myxoma virus (MSW) was able to replicate at the inoculation site of both species but did not induce clinical signs of a disseminated infection. In S. audubonii, there was a rapid response to MSW characterised by a massive T lymphocyte infiltration of the inoculation site by day 5. MSW did not reach transmissible titres at the inoculation site in either species. This might explain why the Californian myxoma virus has not expanded its host-range in North America.
We also recommend Trading Suppliers and Manufacturers of myxoma virus growth factor (cas 108174-48-7). Pls Click Website Link as below: cas 108174-48-7 suppliers
Prev:Molecular and serological analysis of the epidemiology of myxoma virus in rabbits
Next:Oncolytic myxoma virus: The path to clinic) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ReviewOncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds08/31/2019
- Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein08/30/2019
- An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function08/29/2019
- Original ArticleMyxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model08/28/2019
- Original ArticleOncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma08/27/2019
- Oncolytic myxoma virus: The path to clinic08/26/2019
- Molecular and serological analysis of the epidemiology of myxoma virus in rabbits08/24/2019
- Review articleExtracardiac manifestations of atrial myxomas08/23/2019
- ReviewThe immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics08/22/2019


